Clinical Trial Update: TSPO Modulation in AD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from Imperial College London evaluating TSPO modulation in Alzheimer’s disease; the study is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Imperial College London | Conditions: Alzheimer s Disease | Phase 2 | Status: ENROLLING_BY_INVITATION